Barbara-Jean Bormann-Kennedy

Barbara-Jean Bormann-Kennedy

Director/Board Member bij BIOLINERX LTD.

Vermogen: 127 075 $ op 31-03-2024

65 jaar
Health Technology
Consumer Services
Health Services

Profiel

Barbara-Jean Bormann-Kennedy is currently serving as a Director at Rincon Pharmaceuticals, Inc. and Biotechnology Innovation Organization.
She is also an Independent Director at BioLineRx Ltd., Director at Institute For Pediatric Innovation, Inc., Independent Non-Executive Director at Xeris Biopharma Holdings, Inc., Director at Nanomedical Systems, Inc., and VP-Translational Science & Network Alliances at The Jackson Laboratory.
In her former positions, Dr. Bormann-Kennedy served as President, Chief Executive Officer & Director at BetterLife Pharma, Inc., Chief Executive Officer & Director at Harbour Antibodies BV, Chief Executive Officer & Director at Supportive Therapeutics, and Independent Non-Executive Director at Xeris Pharmaceuticals, Inc. She also held the position of Head-Strategic Alliances at Pfizer Inc. and Senior VP-Business Development & Licensing at Boehringer Ingelheim Pharmaceuticals, Inc. Additionally, she worked as a Consultant at Paperboy Ventures LLC.
Dr. Bormann-Kennedy obtained her undergraduate degree from Fairfield University and her doctorate degree from the University of Connecticut Health Center.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
07-06-2023 57 500 ( 0.04% ) 127 075 $ 31-03-2024
15-03-2024 0 ( -.--% ) - $ 31-03-2024

Actieve functies van Barbara-Jean Bormann-Kennedy

BedrijvenFunctieBegin
BIOLINERX LTD. Director/Board Member 19-08-2013
XERIS BIOPHARMA HOLDINGS, INC. Director/Board Member 05-10-2021
Director/Board Member -
Director/Board Member -
Director/Board Member -
Corporate Officer/Principal 01-08-2017
Director/Board Member -
Alle actieve functies van Barbara-Jean Bormann-Kennedy

Eerdere bekende functies van Barbara-Jean Bormann-Kennedy

BedrijvenFunctieEinde
Director/Board Member 05-10-2021
Supportive Therapeutics Chief Executive Officer 01-07-2017
░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Barbara-Jean Bormann-Kennedy in detail bekijken

Opleiding van Barbara-Jean Bormann-Kennedy

Fairfield University Undergraduate Degree
University of Connecticut Health Center Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Barbara-Jean Bormann-Kennedy in detail bekijken

Connecties

100 +

Eerstegraads connecties

16

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven4
PFIZER, INC.

Health Technology

BETTERLIFE PHARMA INC.

Health Technology

BIOLINERX LTD.

Health Technology

XERIS BIOPHARMA HOLDINGS, INC.

Health Technology

Bedrijven in privébezit10

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

Health Services

Health Services

Supportive Therapeutics

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Barbara-Jean Bormann-Kennedy